Riskpilot← Back to searchSign inGet full accessSYNSOPPLEVELSER SØGNE AS
ASActiveOrg 984842945Torvgada 5, 4640 SøgneRetail sale of medical and orthopaedic goods · NACE 4774Est. 20025 employees
Revenue 2024
NOK 8,1M
+5% vs 2023
EBITDA margin
3.5%
+197% vs 2023
Equity ratio
25.1%
Financial strength
Net profit 2024
NOK 215K
+270% vs 2023
| Revenue | NOK 8,1M | +5% |
| EBITDA | NOK 280K | +197% |
| Net profit | NOK 215K | +270% |
| Total assets | NOK 1,5M | +20% |
| Equity | NOK 385K | +33% |
| Employees | 5 | — |
Legal name
SYNSOPPLEVELSER SØGNE AS
Org number
984842945
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
10. september 2002
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Arbeide for bedre synsopplevelser ved salg av tjenester og produkter innenfor området briller, kontaktlinser, synsprøver og svaksynthjelpemidler, og ellers alt hva hermed står i forbindelse, herunder å delta i andre selskap.
Address
Torvgada 5, 4640 Søgne
Phone
+4740411040
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 572 | 6 355 | 6 688 | 7 693 | 8 082 |
| Staff expenses | −1 725 | −2 131 | −2 365 | −2 654 | −2 602 |
| EBITDA | 305 | 73 | −24 | 94 | 280 |
| Depreciation & amort. | −29 | −45 | −46 | −32 | −13 |
| EBIT | 276 | 27 | −71 | 63 | 267 |
| Net financials | 1 | 0 | 3 | 1 | 4 |
| Profit before tax | 278 | 27 | −68 | 64 | 271 |
| Tax | 60 | 6 | −0 | 6 | 56 |
| Net profit | 218 | 22 | −68 | 58 | 215 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 264 | 999 | 1 062 | 1 280 | 1 531 |
| Equity | 348 | 300 | 232 | 290 | 385 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 915 | 699 | 830 | 990 | 1 147 |
| Total debt | 915 | 699 | 830 | 990 | 1 147 |
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
25.1%
This company
38.2%
Market median
-34% vs market
20202024
Return on equity
55.8%
This company
18.4%
Market median
+203% vs market
20202024
Net profit margin
2.7%
This company
8.1%
Market median
-67% vs market
20202024
Asset turnover
5.28×
This company
1.12×
Market median
+371% vs market
20202024
Debt / equity
2.98×
This company
0.62×
Market median
-381% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SYNSOPPLEVELSER SØGNE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helene Severinsen | Board of Directors | 0 companies |
| Jan Olav Furuborg | Chairman | 0 companies |